PRESS RELEASE
News
-
-
-
PRESS RELEASE
FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION
Ferrosa Therapeutics announces USD 3.5 Million seed financing to advance first-in-class bispecific antibody program for anemia of inflammation. Company targets chronic kidney disease, autoimmune disease, and cancer -
PRESS RELEASE
CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)
CorTec GmbH's Brain Interchange™ accepted into FDA Total Product Life Cycle Advisory Program (TAP), showcasing innovation in stroke motor rehabilitation. Third patient successfully implanted in NIH-funded trial -
-
PRESS RELEASE
Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
Lobe Sciences welcomes White House Executive Order supporting advancements in neurology and mental health treatments, focusing on scientific research and compound evaluation -
-
-
PRESS RELEASE
clearvise optimizes portfolio by capitalizing on favorable market conditions: Successful sale of small-scale PV division
clearvise AG optimizes portfolio by selling small-scale PV division to focus on larger wind and solar parks, attracting investors and improving operational efficiency -
